Literature DB >> 23909954

Rosacea and cardiovascular risk factors: a case control study.

N Duman1, S Ersoy Evans, N Atakan.   

Abstract

BACKGROUND AND
OBJECTIVE: Rosacea is an inflammatory skin disease with a chronic course. This study aimed to investigate the risk of cardiovascular disease (CVD) in rosacea patients.
MATERIALS AND METHODS: The study included 60 rosacea patients and 50 age- and gender-matched controls. Demographic data, medical history, presence of cardiovascular risk factors were recorded. Waist circumference, height, and weight were measured, and the body mass index was calculated for each participant. Laboratory investigations, including fasting blood glucose, C-reactive protein (CRP), very low-density lipoprotein, low-density lipoprotein (LDL), high-density lipoprotein, total cholesterol, triglyceride, lipoprotein(a) were performed.
RESULTS: In all, 66% of the rosacea patients were female (mean age: 44.65 ± 12.9 years) and 66% of the controls were female (mean age: 42.3 ± 12.3 years). Median disease duration in the rosacea group was 36 months. High total cholesterol (>200 mg/dL), LDL (>130 mg/dL) and CRP (>0.8 mg/L) levels, a family history of premature CVD, and a history of smoking and alcohol consumption were significantly more common in the rosacea patients compared to controls.
CONCLUSION: Rosacea patients may have a high risk of CVD. As such, we recommend close follow-up of rosacea patients because of the increased risk of CVD. The mechanism underlying this increased risk is unknown, and additional randomized and controlled studies are required for clarification.
© 2013 European Academy of Dermatology and Venereology.

Entities:  

Mesh:

Year:  2013        PMID: 23909954     DOI: 10.1111/jdv.12234

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN: 0926-9959            Impact factor:   6.166


  23 in total

1.  Rosacea, Use of Tetracycline, and Risk of Incident Inflammatory Bowel Disease in Women.

Authors:  Wen-Qing Li; Eunyoung Cho; Hamed Khalili; Shaowei Wu; Andrew T Chan; Abrar A Qureshi
Journal:  Clin Gastroenterol Hepatol       Date:  2015-09-25       Impact factor: 11.382

2.  Cigarette Smoking and Risk of Incident Rosacea in Women.

Authors:  Suyun Li; Eunyoung Cho; Aaron M Drucker; Abrar A Qureshi; Wen-Qing Li
Journal:  Am J Epidemiol       Date:  2017-07-01       Impact factor: 4.897

3.  Relationships of Serum Homocysteine, Vitamin B12, and Folic Acid Levels with Papulopustular Rosacea Severity: A Case-Control Study.

Authors:  Bo Young Chung; Hye One Kim; Chun Wook Park; Na Gyeong Yang; Jae Yun Kim; Yun Su Eun; Euy Hyun Chung; Sung Yul Lee; Young Lip Park; Sang Hoon Lee; Nam Hun Heo; Min Jeong Shin; Jung Eun Kim
Journal:  Biomed Res Int       Date:  2022-07-04       Impact factor: 3.246

4.  Patient Preferences and Therapeutic Satisfaction with Topical Agents for Rosacea: A Survey-Based Study.

Authors:  Todd Williamson; Wendy Y Cheng; Nora McCormick; Francis Vekeman
Journal:  Am Health Drug Benefits       Date:  2018-04

5.  Cardiovascular Risk and Comorbidities in Patients with Rosacea: A Systematic Review and Meta-analysis.

Authors:  Tsung-Yu Tsai; Ying-Yi Chiang; Yu-Chen Huang
Journal:  Acta Derm Venereol       Date:  2020-10-21       Impact factor: 3.875

6.  Evaluation of cardiovascular disease risk factors in patients with mycosis fungoides.

Authors:  Fatma Pelin Cengiz; Nazan Emiroglu
Journal:  An Bras Dermatol       Date:  2015 Jan-Feb       Impact factor: 1.896

Review 7.  Recent advances in the understanding and management of rosacea.

Authors:  Uwe Wollina
Journal:  F1000Prime Rep       Date:  2014-07-08

8.  Thickness of carotid intima and epicardial fat in rosacea: a cross-sectional study.

Authors:  Asli Akin Belli; Ilknur Altun; Ibrahim Altun
Journal:  An Bras Dermatol       Date:  2017 Nov-Dec       Impact factor: 1.896

9.  Serum levels of hypersensitive-C-reactive protein in moderate and severe acne.

Authors:  M R Namazi; A R Parhizkar; F Jowkar
Journal:  Indian Dermatol Online J       Date:  2015 Jul-Aug

10.  Cardiovascular Disease Outcomes Associated with Three Major Inflammatory Dermatologic Diseases: A Propensity-Matched Case Control Study.

Authors:  Vincent D Marshall; Farah Moustafa; Spencer D Hawkins; Rajesh Balkrishnan; Steven R Feldman
Journal:  Dermatol Ther (Heidelb)       Date:  2016-09-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.